SCHEMBL30401708

SCHEMBL30401708

Cc1ccc2c(Cc3ccc(C(F)(F)F)cc3)nccc2c1N

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MBOAT4 Q96T53 2/20 0.39
▸ LTA4H P09960 1/20 0.36
▸ MAOB P27338 2/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ KDM5A P29375 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ KDM5B Q9UGL1 1/20 0.33
▸ NR3C2 P08235 1/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25375372 1.00 MBOAT4 (0.39) MBOAT4LTA4HMAOBTAAR1EGFR
SCHEMBL24399633 0.85 ROCK1 (0.45) LTA4HMAOBTAAR1EGFRNR3C2
SCHEMBL30402694 0.85 ROCK1 (0.45) LTA4HMAOBTAAR1EGFRNR3C2
SCHEMBL30402388 0.85 PARP1 (0.36) NOS3NOS2ALDH1A1
SCHEMBL24399752 0.85 PARP1 (0.36) NOS3NOS2ALDH1A1
SCHEMBL24399590 0.82 FLT1 (0.38) NOS3NOS2ALDH1A1GAA
SCHEMBL30402640 0.82 FLT1 (0.38) NOS3NOS2ALDH1A1GAA
SCHEMBL25379029 0.80 PDE10A (0.53) LTA4HNPC1ALDH1A1ROCK1
SCHEMBL25373908 0.79 ALDH1A1 (0.39) MBOAT4KDM5AKDM4CKDM5BALDH1A1
SCHEMBL30402558 0.79 ALDH1A1 (0.39) MBOAT4KDM5AKDM4CKDM5BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096718-A Aryl amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-05-09 — — CN disclosed
Send feedback